Interferon-gamma Release Tests
"Interferon-gamma Release Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The assay of INTERFERON-GAMMA released from lymphocytes after their exposure to a specific test antigen, to check for IMMUNOLOGIC MEMORY resulting from a previous exposure to the antigen. The amount of interferon-gamma released is usually assayed by an ENZYME-LINKED IMMUNOSORBENT ASSAY.
Descriptor ID |
D059425
|
MeSH Number(s) |
E01.370.225.812.453 E05.200.812.453 E05.478.594.475
|
Concept/Terms |
Interferon-gamma Release Tests- Interferon-gamma Release Tests
- Interferon gamma Release Tests
- Interferon-gamma Release Test
- Release Test, Interferon-gamma
- Release Tests, Interferon-gamma
- Test, Interferon-gamma Release
- Tests, Interferon-gamma Release
- Interferon-gamma Release Assays
- Assay, Interferon-gamma Release
- Assays, Interferon-gamma Release
- Interferon gamma Release Assays
- Interferon-gamma Release Assay
- Release Assay, Interferon-gamma
- Release Assays, Interferon-gamma
|
Below are MeSH descriptors whose meaning is more general than "Interferon-gamma Release Tests".
Below are MeSH descriptors whose meaning is more specific than "Interferon-gamma Release Tests".
This graph shows the total number of publications written about "Interferon-gamma Release Tests" by people in this website by year, and whether "Interferon-gamma Release Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2012 | 1 | 3 | 4 |
2013 | 2 | 0 | 2 |
2014 | 7 | 2 | 9 |
2015 | 4 | 4 | 8 |
2016 | 5 | 2 | 7 |
2017 | 2 | 0 | 2 |
2018 | 3 | 1 | 4 |
2019 | 7 | 0 | 7 |
2020 | 2 | 1 | 3 |
2021 | 2 | 0 | 2 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon-gamma Release Tests" by people in Profiles.
-
Swamy P, Duran C, Gupta A, Misra S, Fredricks K, Cruz AT. Driving to Reduce Socioeconomic Barriers to Latent Tuberculosis Infection Care: A Mobile Pediatric Treatment Program. J Public Health Manag Pract. 2022 Jul-Aug 01; 28(4):E670-E675.
-
Nolt D, Starke JR. Tuberculosis Infection in Children and Adolescents: Testing and Treatment. Pediatrics. 2021 12 01; 148(6).
-
Ronge L, Sloot R, Du Preez K, Kay AW, Kirchner HL, Grewal HMS, Mandalakas AM, Hesseling AC. The Magnitude of Interferon Gamma Release Assay Responses in Children With Household Tuberculosis Contact Is Associated With Tuberculosis Exposure and Disease Status. Pediatr Infect Dis J. 2021 08 01; 40(8):763-770.
-
Lamb GS, Cruz AT, Camp EA, Javier M, Montour J, Piper T, Shah UA, Starke JR. Tuberculosis in Internationally Displaced Children Resettling in Harris County, Texas, USA, 2010-20151. Emerg Infect Dis. 2020 08; 26(8).
-
DiNardo A. Heterogenous Immune Response to TB is Not a False Negative. Am J Trop Med Hyg. 2020 03; 102(3):698.
-
Starke JR. Tuberculin Skin Test Versus the Interferon-? Release Assays: Out With the Old, In With the New. Pediatrics. 2020 01; 145(1).
-
Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, Belknap RW, Ho CS. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection. J Clin Microbiol. 2019 11; 57(11).
-
Cruz AT, Reichman LB. The Case for Retiring the Tuberculin Skin Test. Pediatrics. 2019 06; 143(6).
-
Agarwal S, Nguyen DT, Lew JD, Graviss EA. Discordance between the QuantiFERON Gold In-Tube and QuantiFERON Gold Plus assays associated with country of birth TB incidence. Tuberculosis (Edinb). 2019 05; 116S:S2-S10.
-
Said K, Hella J, Ruzegea M, Solanki R, Chiryamkubi M, Mhimbira F, Ritz N, Schindler C, Mandalakas AM, Manji K, Tanner M, Utzinger J, Fenner L. Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania. Pediatr Infect Dis J. 2019 04; 38(4):333-339.